Articular cartilage defects in the knee present a difficult problem for orthopedic surgeons (see Figure 1). Autologous chondrocyte implantation (ACI) is a cartilage restoration technique that can provide a longer term solution for cartilage injuries, helping to delay the onset of osteoarthritis in the patient down the road. ACI was initially performed in Sweden in 1994 and was FDA approved in the United States soon after. It is a two-stage procedure in which an initial arthroscopy is performed to harvest a small amount of articular cartilage from a nonweight-bearing portion of the knee. The biopsy is sent out for chondrocyte growth, which is at minimum a 5-week process. The cells can be used for up to 5 years.

The second surgery is an open procedure. The site of the defect is debrided, and vertical borders are established (see Figure 2). The area is measured and outlined with a surgical marker. A template of the defect size and shape is made using glove paper or other sterile paper. Periosteum is then harvested from the tibia and trimmed to match the exact dimensions of the defect. Other manufactured patches are currently undergoing FDA review and, if approved, would eliminate the need for the harvest of periosteum. The patch is sewn over the defect with fine 6-0 Vicryl suture and then sealed with fibrin glue. When all but one small area of the patch has been sewn, the watertight seal is tested with sterile saline to ensure there are no areas that will allow the new cartilage cells (chondrocytes) to ooze out. Finally, the chondrocytes are injected under the patch (see Figure 3). The sewing of the patch is completed and the skin closed. The area is protected with a hinged knee brace, and the patient undergoes intensive physical therapy to restore normal function.



A LONGER TERM FIX FOR CARTILAGE INJURY

Articular cartilage lesions are one of many disorders that can cause pain and dysfunction in the knee. Cartilage restoration techniques for focal cartilage defects are becoming increasingly popular, thanks to some of the cutting edge treatments that are available in the United States.

A chondral injury differs from osteoarthritis in several ways. Osteoarthritis is a progressive degenerative disease in which cartilage becomes weak and brittle throughout the joint. Cartilage thins out and wears away, exposing the underlying bone to increased load and friction, causing pain and eventual deformity of the joint. Chondral defects, however, typically occur as the result of an injury and affect a contained area of the cartilage. These lesions are often treated surgically with various techniques, including, but not limited to, chondroplasty (shaving and smoothing the cartilage) and microfracture (drilling tiny holes into the bone to stimulate bleeding, which forms a fibrocartilaginous substance over the lesion). These techniques are not always long-term solutions, however. Much research has gone into newer cartilage restoration techniques to provide better treatments for cartilage defects. ACI is considered an advancement that is able to provide a better, longer-term solution for these difficult cartilage injuries. 
 

EARLY RECOGNITION AND REFERRAL ARE KEY

Cartilage defects have long-term ramifications if not dealt with properly. Early recognition and appropriate orthopedic referral are important and the primary care provider plays an important role in this process. ACI is not for everyone. Insurance companies largely dictate which patients are eligible for the procedure. Because of its high cost, patients who are at higher risk for failure are less likely to be approved.

The primary care provider is often the first to evaluate an injured patient. During primary assessment, radiographs should always be obtained for a new patient with knee pain, especially one with a recent history of trauma. Standard views are bilateral standing, anteroposterior, lateral, and Merchant views of the knee. These are valuable in ruling out fracture or dislocation and for evaluating the joint for early osteoarthritic changes. Osteoarthritis involves the erosion of articular cartilage and overall breakdown of the joint. Associated radiographic changes include joint space narrowing, subchondral sclerosis, formation of osteophytes, and subchondral cyst formation. A patient with existing osteoarthritis in the knee is not a candidate for ACI because the progressive nature of osteoarthritis deters success. The ultimate treatment for osteoarthritis is a total knee replacement. MRI is not typically indicated for a patient with advanced osteoarthritic changes. However, MRI is the diagnostic standard for evaluation of soft tissue.

An ideal candidate for ACI has a well-contained, full-thickness chondral (cartilage tissue) or osteochondral (cartilage and subchondral bone) defect with otherwise healthy cartilage in the knee. A patient with a cartilage defect detected either on MRI or during knee arthroscopy should be referred to an orthopedic surgeon who specializes in cartilage restoration techniques, who will determine if a restoration type procedure is appropriate for the patient. Alignment films will also be taken by the surgeon to determine if a realignment procedure is indicated. A patient with malalignment will have a higher chance of failure if the alignment issue is not addressed with a tibial osteotomy. This is a procedure in which the tibia is cut and a wedge of bone is either inserted or removed to change the angle of alignment. This decreases the amount of force over the site of the defect. 

CAREFUL REHAB AND REALISTIC EXPECTATIONS

Proper postoperative management is important and includes protected weight-bearing and early range of motion (ROM). Overall goals include pain management, regaining ROM, progressive eight bearing, strengthening, and eventual return to more functional activities.

The first 12-week phase focuses on gradually increasing activities until the patient is bearing full weight and regaining ROM. During this phase of recovery, the patient is protected in a hinged knee brace. Patients may also use a continuous passive motion machine to mechanically stimulate healing and to help with regaining ROM. Therapeutic exercise in this phase progresses from isometric to closed chain. The next progression takes the patient from 3 months through 6 months. At this point the patient's goals are to be walking without a limp and to have regained full ROM. If recovery is appropriate, the patient will progress to activities that include closed chain double- and single-leg exercise, as well as starting to work on eccentric strength. The patient may also begin to use an exercise bike and elliptical trainer. During months 6 through 9, patients are expected to be able to do light jogging and to increase functional activities. Most patients are not able to get back to high-impact activities for 16 to 24 months.

It is important that the patient have realistic expectations. A return to “normal” function may not be possible for the patient who has a knee with a large cartilage defect. Instead, management focuses on enabling the patient to lead a relatively pain-free and normal life. The goal of this surgery is to return the patient to a more functional level and to delay the requirement for total joint arthroplasty for as long as possible. JAAPA
 

Sarah Zarbock, PA-C, department editor